Tech Company Financing Transactions
Forge Therapeutics Funding Round
On 12/31/2015, Forge Therapeutics raised $1.8 million in investment from private investors.
Transaction Overview
Company Name
Announced On
12/31/2015
Transaction Type
Venture Equity
Amount
$1,800,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10578 Science Center Dr. 205
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Forge Therapeutics is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. Forge has developed a fundamentally new approach for the discovery of metalloprotein inhibitors by focusing first on the metal in the enzyme active site.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Zachary Zimmerman
Chief Financial Officer
Esther Boom
Chief Operating Officer
David Puerta
Vice President
Min Teng
Browse more venture capital transactions:
Prev: 12/31/2015: Ditto Labs venture capital transaction
Next: 12/31/2015: Abominable Labs venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs